Disrupting Healthcare - De-risking Innovation - Transforming Technologies
BIOASTER is a leading biotechnology research institute dedicated to disrupting healthcare, de-risking innovation, and transforming technologies within the microbiology sector. With a focus on addressing critical challenges such as antimicrobial resistance, vaccine safety and efficacy, rapid infection diagnostics, and the utilization of human and animal microbiota, BIOASTER operates at the forefront of scientific advancement.
Located in Lyon, France at 40 avenue Tony Garnier, BIOASTER fosters collaborative projects that unite academics, startups, SMEs, and industrial groups. These initiatives leverage academic research excellence and are executed by a team of world-class experts and engineers equipped with state-of-the-art infrastructure. BIOASTER's commitment to innovation makes it a key player in the biotechnology landscape.
As an independent non-profit organization, BIOASTER plays a vital role in driving progress in infectious diseases and microbiology. BIOASTER aims to overcome technological bottlenecks and explore new avenues, supported by its extensive network and cutting-edge resources. For more information, management is welcome to provide the latest updates. We invite the management team at BIOASTER to create a customized and exclusive company showcase and product listing on our platform to highlight their groundbreaking work and expand their reach.
Compare BIOASTER with 3 companies in Biotechnology-Research
| Comparison Field |
BIOASTERMain Company |
MIRRI - Microbial Re...View Profile |
United Immunity, Co....View Profile |
Institut Pasteur of...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2012 | 2017 | 2004 |
|
Company Size
|
— | 11-50 | 11-50 | 201-500 |
|
City
|
上海市, 上海市 | |||
|
Country
|
China | |||
|
Skills & Keywords
Comparing with main company
|
12 Total Skills
Biotechnology
Microbiology
Infectious Diseases
Vaccine Development
Antimicrobial Resistance
Diagnostic Technologies
Microbiota Research
Infectious diseases
Vaccines
Antimicrobials
Diagnostic
Microbiota
|
19 Total
19 Unique
Unique Skills:
Advanced biofuels
Biodiversity
Bioeconomy
Biofertilizers
Bioindustries
Biomaterials
+13
|
11 Total
11 Unique
Unique Skills:
Autoimmune diseases
Cancer
Cold to hot tumors
Dentritic cells
Fibrosis
Lipid nanoparticles
+5
|
2 Total
2 Unique
Unique Skills:
Diagnostics
Immunology
|
Other organizations in the same industry
This company is also known as